Search

Your search keyword '"Pharmacophore"' showing total 15,122 results

Search Constraints

Start Over You searched for: Descriptor "Pharmacophore" Remove constraint Descriptor: "Pharmacophore"
15,122 results on '"Pharmacophore"'

Search Results

1. De novo design of drug-binding proteins with predictable binding energy and specificity

2. Inhibitory properties of quinopimaric acid derivatives towards cholinesterases.

3. Synthetic studies on the tetrasubstituted D-ring of cystobactamids lead to potent terephthalic acid antibiotics.

4. Integration of Consensus‐Based Pharmacophore Mapping and Molecular Docking in Sequential Virtual Screening: Toward the Discovery of Novel PI3Kγ Inhibitors.

5. Structure‐Based Computational Approach in Search of the Potent Molecules Targeting Phosphoglycerate Dehydrogenase (PHGDH) Enzyme for Cancer Treatment.

6. Synthesis of Benzofuran‐Based Hybrid Molecules: Molecular Docking and Antibacterial Activity Against Pseudomonas aeruginosa.

7. Discovery of Structural Diversity Guided N‐S Heterocyclic Derivatives Based on Natural Benzothiazole Alkaloids as Potential Cytotoxic Agents.

8. Design, Synthesis, Biological Evaluation and Molecular Modeling Studies of New Aminopyrimidine Derivatives as Potential Anticancer Agents.

9. Phytoconstituents of Withania somnifera (L.) Dunal (Ashwagandha) unveiled potential cerebroside sulfotransferase inhibitors: insight through virtual screening, molecular dynamics, toxicity, and reverse pharmacophore analysis.

10. Radiolabeled iron oxide nanoparticles functionalized with PSMA/BN ligands for dual-targeting of prostate cancer.

11. A novel hypothesis‐generating computational workflow utilizing reverse pharmacophore mapping—A drug repurposing perspective of istradefylline towards major depressive disorder.

12. Enantioselective S‐Alkylation of Sulfenamides by Phase‐Transfer Catalysis.

13. Synthesis and Utilization of 1 H -Indazole N -Oxides in the Production of C3-Functionalized 1 H -Indazoles.

14. Screening of Novel Hydroxamic Acid Derivatives as ASM Inhibitors for the Treatment of Depression.

15. Perry Disease: Current Outlook and Advances in Drug Discovery Approach to Symptomatic Treatment.

16. Subcellular activation of β-adrenergic receptors using a spatially restricted antagonist.

17. Experimental and Computational Insights Into Organotellurium (IV) Complexes as Potent PfNDH2 Inhibitors: Synthesis, Characterization, and Antimalarial Evaluation.

18. Random Forests Regression and Rescoring Strategy for Identifying Inhibitors of Ubiquitin Specific Protease-7.

19. From roots to codes: Applications of computer-aided drug discovery from medicinal plants.

20. THE CO-DRUG STRATEGY FOR METABOLIC DISEASES AND COMORBIDITY MANAGEMENT: A COMPREHENSIVE REVIEW.

21. Exhaustive computational studies on pyrimidine derivatives as GPR119 agonist for the development of compounds against NIDDM.

22. The identification of potent dual-target monopolar spindle 1 (MPS1) and histone deacetylase 8 (HDAC8) inhibitors through pharmacophore modeling, molecular docking, molecular dynamics simulations, and biological evaluation.

23. Identification of novel PHGDH inhibitors based on computational investigation: an all-in-one combination strategy to develop potential anti-cancer candidates.

24. Mechanism of emergency phytoremediation technology based on a 3D-QSAR pharmacological model.

25. Molecular insights into kaempferol derivatives as potential inhibitors for CDK2 in colon cancer: pharmacophore modeling, docking, and dynamic analysis.

26. Synthesis of sildenafil and its derivatives bearing pyrazolo‐pyrimidinones scaffold.

27. Discovery of novel chemotype inhibitors targeting Anaplastic Lymphoma Kinase receptor through ligand-based pharmacophore modelling.

28. In Silico Exploration of Novel EGFR Kinase Mutant-Selective Inhibitors Using a Hybrid Computational Approach.

29. Synthesis of Hybrid Molecules with Imidazole-1,3,4-thiadiazole Core and Evaluation of Biological Activity on Trypanosoma cruzi and Leishmania donovani.

30. Identification of Novel Bromodomain-Containing Protein 4 (BRD4) Binders through 3D Pharmacophore-Based Repositioning Screening Campaign.

31. ISATIN: REVIEW OF SYNTHESIS, REACTIVITY, AND ANTI-INFECTIVE PROPERTIES.

32. COMPUTER MODELS FOR THE PREDICTION OF ANTIMICROBIAL ACTIVITY OF 4-((5-(DECYLTHIO)-4-METHYL-4H-1,2,4-TRIAZOL-3-YL)METHYL)MORPHOLINE AS A POTENTIAL MEDICINE.

33. Virtual design and screening of new (+)-catechin derivates N- and/or S-heterocyclic fragment for anti-malarial and anti-SARS-CoV-2 activities by In silico simulation.

34. Pharmacophore-based virtual screening toward the discovery of novel antioxidant compounds from alkaloids in honey products.

35. In Silico Analysis for Exploring the Potential Inhibitors Against Breast Cancer (MCF7) Using Curcumin Analogue Compounds

36. Pharmacophore mapping, 3D QSAR, molecular docking, and ADME prediction studies of novel Benzothiazinone derivatives.

37. Insights Into Benzothiazolyl‐Coupled Azetidinone Moieties Toward EGFR Binding and Stability Analysis—Evidence From Molecular Docking and Dynamics Simulation.

38. Imidazole‐Oxadiazole Hybrid as Potential Antimicrobial Agents: Design, Synthesis, Drug–Likeness, Pharmacophore and Molecular Docking Study.

39. Identifying Potent Breast Cancer Inhibitors Against ERα Target Using Pharmacophore Model, 3D‐QSAR and MD Studies.

40. Antibacterial activity of natural flavones against bovine mastitis pathogens: in vitro, SAR analysis, and computational study.

41. Structural Characterization of Heat Shock Protein 90β and Molecular Interactions with Geldanamycin and Ritonavir: A Computational Study.

42. In Silico Design, Chemical Synthesis, Biophysical and in Vitro Evaluation for the Identification of 1‐Ethyl‐1H‐Pyrazolo[3,4‐b]Pyridine‐Based BRD9 Binders.

43. Building shape-focused pharmacophore models for effective docking screening.

44. Rosmarinic acid: Potential antiviral agent against dengue virus - In silico evaluation.

45. Unlocking the Potential of Clustering and Classification Approaches: Navigating Supervised and Unsupervised Chemical Similarity.

46. Computational discovery of dual potential inhibitors of SARS‐CoV‐2 spike/ACE2 and Mpro: 3D-pharmacophore, docking-based virtual screening, quantum mechanics and molecular dynamics.

47. Lessons learned in application driven imaging agent design for image-guided surgery.

48. Identification of aryl hydrocarbon receptor allosteric antagonists from clinically approved drugs.

49. Design, Synthesis, and Biological Evaluation of Quinoline (Quinolinone) Derivatives as NADPH Oxidase (NOX) Inhibitors.

50. Structure‐based pharmacophore modeling for precision inhibition of mutant ESR2 in breast cancer: A systematic computational approach.

Catalog

Books, media, physical & digital resources